Breast Cancer Archive - Seite 6 von 17 - IOZK

A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer

2018-01-10/in Breast Cancer, Dendritic Cells, International Publications /von 2018-01-10 / Oncotarget 2018 Feb;9(11):10110-10117

Association of autologous AdHER2 dendritic cell vaccination with antitumor activity and number of circulating tumor cells.

2017-06-05/in Breast Cancer, Dendritic Cells, International Publications /von 2017-06-05 / J Clin Oncol 35, 2017 (suppl; abstr 3089)

Reirradiation for locally recurrent breast cancer

2017-04-07/in Breast Cancer, Hyperthermia, International Publications /von 2017-04-07 / Breast 2017 Jun;33:159-165

Optimizing non-invasive radiofrequency hyperthermia treatment for improving drug delivery in 4T1 mouse breast cancer model

2017-03-13/in Breast Cancer, Hyperthermia, International Publications /von 2017-03-13 / Sci Rep 2017 03;7:43961

Progress in Vaccine Therapies for Breast Cancer

2017-01-01/in Breast Cancer, Dendritic Cells, International Publications /von 2017-01-01 / Adv Exp Med Biol 2017;1026:315-330

Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 DCIS Independent of Route: Results of Randomized Selection Design Trial

2016-12-13/in Breast Cancer, Dendritic Cells, International Publications /von 2016-12-13 / Clin Cancer Res 2017 Jun;23(12):2961-2971

Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy

2016-10-04/in Breast Cancer, Hyperthermia, International Publications /von 2016-10-04 / Oncotarget 2016 Oct;7(40):65042-65051

Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results

2016-07-21/in Breast Cancer, Dendritic Cells, International Publications /von 2016-07-21 / Onco Targets Ther 2016;9:4441-51

Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER/HER2 early breast cancer

2016-07-01/in Breast Cancer, Dendritic Cells, International Publications /von 2016-07-01 / Oncoimmunology 2017;6(9):e1207032

Anti-tumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro.

2016-06-17/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-17 / J Clin Oncol 36, 2018 (suppl; abstr e24000)